Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Studerus, Erich, Kometer, Michael, Hasler, Felix, Vollenweider, Franz X · 2011 · Journal of Psychopharmacology

Abstract

Psilocybin and related hallucinogenic compounds are increasingly used in human research. However, due to limited information about potential subjective side effects, the controlled medical use of these compounds has remained controversial. We therefore analysed acute, short- and long-term subjective effects of psilocybin in healthy humans by pooling raw data from eight double-blind placebo-controlled experimental studies conducted between 1999 and 2008. The analysis included 110 healthy subjects who had received 1–4 oral doses of psilocybin (45–315 µg/kg body weight). Although psilocybin dose-dependently induced profound changes in mood, perception, thought and self-experience, most subjects described the experience as pleasurable, enriching and non-threatening. Acute adverse drug reactions, characterized by strong dysphoria and/or anxiety/panic, occurred only in the two highest dose conditions in a relatively small proportion of subjects. All acute adverse drug reactions were successfully managed by providing interpersonal support and did not need psychopharmacological intervention. Follow-up questionnaires indicated no subsequent drug abuse, persisting perception disorders, prolonged psychosis or other long-term impairment of functioning in any of our subjects. The results suggest that the administration of moderate doses of psilocybin to healthy, high-functioning and well-prepared subjects in the context of a carefully monitored research environment is associated with an acceptable level of risk.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881110382466

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 91 references

Research works printed but not linked: 32

  1. Bodmer I, 1999, Erinnerung an einen aussergewöhnlichen Bewusstseinszustand: Eine experimentelle Untersuchung zum autobiographischen Gedächtnis [Recollection of an altered state of consciousness: An experimental study on the autobiographic memory]
  2. Braun I (1997) Zur quantitativen Beschreibung aussergewöhnlicher Bewusstseinszustände im fünfdimensionalen Raum: Eine empirische Studie [On the quantitative description of altered states of consciousness in the five-dimensional space: An empirical study]. Master’s thesis, University of Zürich.
  3. Cerletti A, 1959, Neuro-Pharmacology
  4. Clark B, 1968, Brit J Soc Psychiat, 2, 21
  5. David AE, 1961, Acta Neuropsiquiatr Argent, 7, 143
  6. Derogatis LR, 1994, SCL-90-R: Symptom Checklist-90-R. Administration, scoring and procedures manual
  7. Dittrich A, 1994, 50 Years of LSD. Current Status and Perspectives of Hallucinogens
  8. Dittrich A, 2006, 5D-ABZ: Fragebogen zur Erfassung Aussergewöhnlicher Bewusstseinszustände. Eine kurze Einführung. [5D-ASC: Questionnaire for the Assessment of Altered States of Consciousness. A Short Introduction]
  9. Dittrich A, 1985, Germ J Psych, 9, 319
  10. Doblin R, 1991, J Transpersonal Psychol, 23, 1
  11. Fahrenberg J, 1984, Das Freiburger Persönlichkeitsinventar FPI [The Freiburg Personality Inventory FPI]
  12. Guzmán G, 2000, Ann Mus Civico Rovereto, 14, 189
  13. Hasler F, 2009, Neuropsychobiology, 59, 2
  14. Heimann H, 1962, Schweiz Arch Neurol Neurochir Psychiatr, 89, 214
  15. Hofmann A, 1968, Chemical constitution and pharmacodynamic actions
  16. Hollister LE, 1961, Arch Int Pharmacodyn Ther, 130, 42
  17. Janke W, 1978, Die Eigenschaftswörterliste (EWL-K) [The Adjective Word List EWL-K]
  18. Janke W, 1986, Die Eigenschaftswörterliste EWL 60 S [The Adjective Word List EWL-60 S]. Internationale Skalen für Psychiatrie
  19. Leuner H, 1968, Nervenarzt, 39, 356
  20. Leuner H, 1981, Halluzinogene: Psychische Grenzzustände in Forschung und Therapie [Hallucinogens: Psychological Borderline States in Research and Therapy]
  21. Metzner R, 1965, Psychedelic Rev, 5, 3
  22. Nichols DE, 2006, The neuropharmacology of religious experience: Hallucinogens and the experience of the divine. Where God and Science meet. How brain and evolutionary studies alter our understanding of religion
  23. Nieto D, 1962, Neurol Neuocir Psiquiat, 3, 140
  24. Pahnke W, 1969, Int Psychiatry Clin, 5, 149
  25. Passie T, 1995, Curare, 18, 131
  26. Pinheiro JC, 2008, nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-90 ed
  27. Rümmele W, 1961, Schweiz Arch Neurol Psychiatr, 87, 365
  28. Vollenweider FX, 1992, SUCHT Wissenschaft Praxis, 38, 398
  29. Vollenweider FX, 2008, Fundam Clin Pharmacol, 22, 113
  30. von Zerssen D, 1971, Therapiewoche, 25, 1908
  31. Wasson RG, 1958, Les champignons hallucinogenes du Mexique [The hallucinogenic mushrooms of Mexico]
  32. Wittchen HU, 1997, DIA-X-Interview

Cited by

See all 532

Metadata

Authors
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X.
Affiliations
University of Zurich (CH)
Corresponding author
Studerus, Erich
Venue
Journal of Psychopharmacology
Published
2010-09-20
Volume
25
Issue
11
Pages
1434-1452
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W1981740630
Cited by
532
References
91
Citations by year
2026: 37 · 2025: 46 · 2024: 57 · 2023: 88 · 2022: 54 · 2021: 44 · 2020: 38 · 2019: 20 · 2018: 22 · 2017: 33 · 2016: 31 · 2015: 16 · 2014: 14 · 2013: 12 · 2012: 12
FWCI
10.86
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • edoc (University of Basel) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
psilocybin, subjective effects, adverse drug reactions, hallucinogens, dose dependence, dysphoria, anxiety, long-term follow-up, interpersonal support
MeSH terms
Adult, Affect, Double-Blind Method, Female, Follow-Up Studies, Hallucinogens, Humans, Male, Middle Aged, Perception, Psilocybin, Surveys and Questionnaires, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. https://app.cochat.ai/papers/10.1177/0269881110382466
The paper
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Journal of Psychopharmacology. https://doi.org/10.1177/0269881110382466

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.